Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00907413 · ClinicalTrials.gov registry record · Phase 3
Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma
A Phase 3 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
NCT00907413 is a Phase 3 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 50 participants.
The verdict
NCT00907413, a Phase 3 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
Study Summary
This research study is a phase III double arm, multicenter, randomized controlled clinical trial comparing endoscopic retrograde cholangiopancreatography (ERCP) and stenting plus photodynamic therapy (PDT) versus ERCP with stenting alone in adult patients with unresectable cholangiocarcinoma. The study objectives are to investigate the efficacy of photodynamic therapy (PDT) in increasing the survival time of patients with unresectable cholangiocarcinoma and to assess the effect of PDT on both cholestasis and health-related quality of life (HRQoL).
Interventions
- PROCEDURE ERCP and Photodynamic Therapy
- PROCEDURE ERCP only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00907413
The ClinicalTrials.gov registry entry for NCT00907413 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ERCP and Photodynamic Therapy is the first listed.
NCT00907413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00907413 about?
NCT00907413 is a clinical study titled "Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma". This research study is a phase III double arm, multicenter, randomized controlled clinical trial comparing endoscopic retrograde cholangiopancreatography (ERCP) and stenting plus photodynamic therapy (PDT) versus ERCP with stenting alone in adult patients with unresectable cholangiocarcinoma. The s...
What is the current status of trial NCT00907413?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2010-05. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00907413?
The interventions under investigation include: ERCP and Photodynamic Therapy (PROCEDURE), ERCP only (PROCEDURE).
Who is sponsoring clinical trial NCT00907413?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.